JPRN-jRCTs041200024进行中（未招募）2 期
Randomized Placebo-controlled Multicenter Trial of Epicutaneous Immunotherapy using Casein Hydrolyte Protein-containing Hydrophilic Gel Patch for Children with Sever Milk Allergy
Takase Takafumi0 个研究点目标入组 40 人开始时间: 2020年6月26日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 2age old 至 <= 15age old（—）
- 性别
- All
入选标准
- •1.IgE-mediated milk allergy
- •2.Immediate allergic symptoms are induced in oral milk challenge by cumulative dose of milk at 3 ml or less
- •3.Written informed consent by a guardian and informed ascent by a participant(child)
排除标准
- •Uncontrolled atopic dermatitis/bronchial asthma
研究者
相似试验
招募中
不适用
A Randomised Multi-centre Placebo Controlled Trial of Fenofibrate for Treatment of Diabetic Macular Oedema with Economic Evaluation (FORTE Study)ACTRN12618000592246niversity of Sydney392
已完成
不适用
Multicenter, placebo-controlled randomized trial for prevention of post ERCP pancreatitis with Risperidonepost ERCP pancreatitisJPRN-UMIN000004592Faculty of Medicine, University of Tokyo500
进行中（未招募）
1 期
Randomized, placebo-controlled multicenter trial of lithium plus treatment asusual (TAU) for acute suicidal ideation and behaviour in patients with suicidalmajor depressive episodeDiagnosis of a major depressive episodeinpatient at screening visitsuicidalideation/behaviour present defined by a clinical rating of = 8 on the SheehanSuicidality Tracking Scale (S-STS) at screening and a rating of =20 on the MontgomeryAsberg Depression Scale (MADRS) at both screening and baseline visitsbothgender, age =18 years.MedDRA version: 20.0Level: PTClassification code 10012397Term: Depression suicidalSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2013-000970-31-DETechnische Universität Dresden254
进行中（未招募）
1 期
AEUCTR2016-002072-26-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)450
招募中
2 期
Dextran in Carotid Endarterectomy TrialCarotid Endarterectomy and ThromboembolismStroke - IschaemicACTRN12609000673246ational Stroke Research Institute and John Hunter Health1,412